InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,229.01
(
-0.02%
)
US TECH 100
22,077.60
(
-0.02%
)
Dow Jones
44,329.58
(
-0.17%
)
Brent Oil
69.82
(
0.79%
)
Bitcoin
108,345.00
(
0.02%
)
Post# of 493297
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

dia76ca

Send PM Follow Ignore
Followers 58
Posts 5897
Boards Moderated 0
Alias Born 12/13/2004

dia76ca

Re: None

Thursday, 04/24/2025 11:42:48 AM

Thursday, April 24, 2025 11:42:48 AM

Post# of 493297
Some think an Anavex buyout might be at more than $200 a share?

Any calculation must include Worldwide sales of Blarcamesine to treat early Alzheimer's. But it must also include its early use in preventing Alzheimer's. And it must also include its use against Parkinson's ,Rett and several other indications.

And any buyout would include Anavex 3-71 which has shown activity against Schizophrenia, Alzheimer's and Frontotemporal Dementia. In fact both Blarcamesine and A3-71 may be active against dozens of CNS diseases!

It is not an exaggeration to say that in a few years Anavex will become the world leader in the treatment of Central Nervous System diseases!

IMO any Big Pharma who wants to buyout Anavex will have to pay multiples of $200 to even be considered!
Bullish
Bullish

"The refusal of the real is the number one dogma of our time" Rene Girard

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • Jul 8, 2025 8:30 AM

Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM

VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM

Patented, Groundbreaking Blockchain for Public Companies 'BlackStar Digital Trading PlatformTM' can Facilitate U.S. Registered Securities to Trade on Blockchain Without Tokens. • BEGI • Jul 1, 2025 12:54 PM

UC Asset (UCASU) Public Offering's Acquisition Target Reported Better Results • UCASU • Jul 1, 2025 9:15 AM

Start posting your company's news
Only $200 per official company press release!